{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:48:22Z","timestamp":1794358102089,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Acyl coenzyme A binding protein (ACBP), also known as diazepam binding inhibitor (DBI) is a multifunctional protein with an intracellular action (as ACBP), as well as with an extracellular role (as DBI). The plasma levels of soluble ACBP\/DBI are elevated in human obesity and reduced in anorexia nervosa. Accumulating evidence indicates that genetic or antibody-mediated neutralization of ACBP\/DBI has anorexigenic effects, thus inhibiting food intake and inducing lipo-catabolic reactions in mice. A number of anorexiants have been withdrawn from clinical development because of their side effects including an increase in depression and suicide. For this reason, we investigated the psychiatric impact of ACBP\/DBI in mouse models and patient cohorts. Intravenously (i.v.) injected ACBP\/DBI protein conserved its orexigenic function when the protein was mutated to abolish acyl coenzyme A binding, but lost its appetite-stimulatory effect in mice bearing a mutation in the \u03b32 subunit of the \u03b3-aminobutyric acid (GABA) A receptor (GABA<jats:sub>A<\/jats:sub>R). ACBP\/DBI neutralization by intraperitoneal (i.p.) injection of a specific mAb blunted excessive food intake in starved and leptin-deficient mice, but not in ghrelin-treated animals. Neither i.v. nor i.p. injected anti-ACBP\/DBI antibody affected the behavior of mice in the dark\u2013light box and open-field test. In contrast, ACBP\/DBI increased immobility in the forced swim test, while anti-ACBP\/DBI antibody counteracted this sign of depression. In patients diagnosed with therapy-resistant bipolar disorder or schizophrenia, ACBP\/DBI similarly correlated with body mass index (BMI), not with the psychiatric diagnosis. Patients with high levels of ACBP\/DBI were at risk of dyslipidemia and this effect was independent from BMI, as indicated by multivariate analysis. In summary, it appears that ACBP\/DBI neutralization has no negative impact on mood and that human depression is not associated with alterations in ACBP\/DBI concentrations.<\/jats:p>","DOI":"10.1038\/s41419-020-2716-5","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T08:03:49Z","timestamp":1594022629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)\/diazepam binding inhibitor (DBI)"],"prefix":"10.1038","volume":"11","author":[{"given":"Adrien","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Moriceau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-8675","authenticated-orcid":false,"given":"Gerasimos","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-7562","authenticated-orcid":false,"given":"Jonathan","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-5728","authenticated-orcid":false,"given":"Antoine","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bellivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Belzeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Etain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Capdevielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Courtet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dubreucq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u2019. Amato","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Gard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Michel","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Oli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Passerieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Polosan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Samalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Schwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FACE-SZ and FACE-BD (FondaMental Academic Centers of Expertise, for Schizophrenia and for Bipolar Disorder) Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Magnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Oury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Bravo-San Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"2716_CR1","doi-asserted-by":"publisher","first-page":"107386","DOI":"10.1016\/j.pharmthera.2019.06.008","volume":"208","author":"M-C Tonon","year":"2020","unstructured":"Tonon, M.-C. et al. Endozepines and their receptors: structure, functions and pathophysiological significance. Pharmacol. Ther. 208, 107386 (2020).","journal-title":"Pharmacol. Ther."},{"key":"2716_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cmet.2019.10.011","volume":"30","author":"JM Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro, J. M. et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metab. 30, 1171 (2019).","journal-title":"Cell Metab."},{"key":"2716_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/eat.22129","volume":"46","author":"E Conti","year":"2013","unstructured":"Conti, E. et al. Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. Int. J. Eat. Disord. 46, 626\u2013629 (2013).","journal-title":"Int. J. Eat. Disord."},{"key":"2716_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s13054-014-0633-7","volume":"18","author":"T Clavier","year":"2014","unstructured":"Clavier, T. et al. Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study. Crit. Care Lond. Engl. 18, 633 (2014).","journal-title":"Crit. Care Lond. Engl."},{"key":"2716_CR5","first-page":"2907","volume":"83","author":"P Dandona","year":"1998","unstructured":"Dandona, P. et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83, 2907\u20132910 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2716_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177\u2013185 (2017).","journal-title":"Nature"},{"key":"2716_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1083\/jcb.200911149","volume":"188","author":"R Manjithaya","year":"2010","unstructured":"Manjithaya, R., Anjard, C., Loomis, W. F. & Subramani, S. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J. Cell Biol. 188, 537\u2013546 (2010).","journal-title":"J. Cell Biol."},{"key":"2716_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2205-x","volume":"11","author":"N Charmpilas","year":"2020","unstructured":"Charmpilas, N. et al. Acyl-CoA-binding protein (ACBP): a phylogenetically conserved appetite stimulator. Cell Death Dis. 11, 7 (2020).","journal-title":"Cell Death Dis."},{"key":"2716_CR9","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0501820102","volume":"102","author":"C Anjard","year":"2005","unstructured":"Anjard, C. & Loomis, W. F. Peptide signaling during terminal differentiation of Dictyostelium. Proc. Natl Acad. Sci. USA 102, 7607\u20137611 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2716_CR10","doi-asserted-by":"publisher","first-page":"38417","DOI":"10.1074\/jbc.M111.267344","volume":"286","author":"M Ryuda","year":"2011","unstructured":"Ryuda, M. et al. Identification of a novel gene, anorexia, regulating feeding activity via insulin signaling in Drosophila melanogaster. J. Biol. Chem. 286, 38417\u201338426 (2011).","journal-title":"J. Biol. Chem."},{"key":"2716_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2019.1667193","volume":"6","author":"JM Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro, J. M., Sica, V. & Kroemer, G. The elusive \u2018hunger protein\u2019: an appetite-stimulatory factor that is overabundant in human obesity. Mol. Cell. Oncol. 6, e1667193 (2019).","journal-title":"Mol. Cell. Oncol."},{"key":"2716_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.15698\/cst2019.10.200","volume":"3","author":"JMB-S Pedro","year":"2019","unstructured":"Pedro, J. M. B.-S., Sica, V., Madeo, F. & Kroemer, G. Acyl-CoA-binding protein (ACBP): the elusive \u2018hunger factor\u2019 linking autophagy to food intake. Cell Stress 3, 312\u2013318 (2019).","journal-title":"Cell Stress"},{"key":"2716_CR13","doi-asserted-by":"crossref","unstructured":"Henry, C. et al. Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD]). Bipolar Disord. 19, 651\u2013660 (2017).","DOI":"10.1111\/bdi.12539"},{"key":"2716_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.schres.2015.07.047","volume":"168","author":"O Godin","year":"2015","unstructured":"Godin, O. et al. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort. Schizophr. Res. 168, 388\u2013394 (2015).","journal-title":"Schizophr. Res."},{"key":"2716_CR15","doi-asserted-by":"crossref","unstructured":"Godin, O. et al. Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia: the FACE-SZ cohort. J. Clin. Psychiatry 79, 17m12007 (2018).","DOI":"10.4088\/JCP.17m12007"},{"key":"2716_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","volume":"54","author":"U Rudolph","year":"2014","unstructured":"Rudolph, U. & M\u00f6hler, H. GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. Annu. Rev. Pharmacol. Toxicol. 54, 483\u2013507 (2014).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2716_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan, E. et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72, 268\u2013275 (2015).","journal-title":"JAMA Psychiatry"},{"key":"2716_CR18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1909340117","author":"RAM Marino","year":"2020","unstructured":"Marino, R. A. M. et al. Control of food approach and eating by a GABAergic projection from lateral hypothalamus to dorsal pons. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1909340117 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2716_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ebiom.2018.03.019","volume":"30","author":"AK Bhandage","year":"2018","unstructured":"Bhandage, A. K. et al. GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes. EBioMedicine 30, 283\u2013294 (2018).","journal-title":"EBioMedicine"},{"key":"2716_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nn1927","volume":"10","author":"P Wulff","year":"2007","unstructured":"Wulff, P. et al. From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors. Nat. Neurosci. 10, 923\u2013929 (2007).","journal-title":"Nat. Neurosci."},{"key":"2716_CR21","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1021\/bi982427c","volume":"38","author":"BB Kragelund","year":"1999","unstructured":"Kragelund, B. B. et al. Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein. Biochemistry 38, 2386\u20132394 (1999).","journal-title":"Biochemistry"},{"key":"2716_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-00328-3","volume":"11","author":"J Fregeac","year":"2020","unstructured":"Fregeac, J. et al. Loss of the neurodevelopmental disease-associated gene miR-146a impairs neural progenitor differentiation and causes learning and memory deficits. Mol. Autism 11, 22 (2020).","journal-title":"Mol. Autism"},{"key":"2716_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/7854_2010_108","volume":"7","author":"V Krishnan","year":"2011","unstructured":"Krishnan, V. & Nestler, E. J. Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 7, 121\u2013147 (2011).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"2716_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGMM Alberti","year":"2005","unstructured":"Alberti, K. G. M. M., Zimmet, P. & Shaw, J. IDF Epidemiology Task Force Consensus Group The metabolic syndrome-a new worldwide definition. Lancet 366, 1059\u20131062 (2005).","journal-title":"Lancet"},{"key":"2716_CR25","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1091\/mbc.e06-01-0035","volume":"17","author":"MK Larsen","year":"2006","unstructured":"Larsen, M. K., Tuck, S., Faergeman, N. J. & Knudsen, J. MAA-1, a novel acyl-CoA-binding protein involved in endosomal vesicle transport in Caenorhabditis elegans. Mol. Biol. Cell 17, 4318\u20134329 (2006).","journal-title":"Mol. Biol. Cell"},{"key":"2716_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuron.2017.03.003","volume":"94","author":"I Dumitru","year":"2017","unstructured":"Dumitru, I., Neitz, A., Alfonso, J. & Monyer, H. Diazepam binding inhibitor promotes stem cell expansion controlling environment-dependent neurogenesis. Neuron 94, 125\u2013137.e5 (2017).","journal-title":"Neuron"},{"key":"2716_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph, U. & Knoflach, F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat. Rev. Drug Discov. 10, 685\u2013697 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2716_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrendo.2017.122","volume":"14","author":"G Srivastava","year":"2018","unstructured":"Srivastava, G. & Apovian, C. M. Current pharmacotherapy for obesity. Nat. Rev. Endocrinol. 14, 12\u201324 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2716_CR29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s40263-019-00664-w","volume":"33","author":"E Galaj","year":"2019","unstructured":"Galaj, E. & Xi, Z.-X. Potential of cannabinoid receptor ligands as treatment for substance use disorders. CNS Drugs 33, 1001\u20131030 (2019).","journal-title":"CNS Drugs"},{"key":"2716_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0091-3057(87)90006-2","volume":"28","author":"C Belzung","year":"1987","unstructured":"Belzung, C., Misslin, R., Vogel, E., Dodd, R. H. & Chapouthier, G. Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light\/dark choice situation. Pharmacol. Biochem. Behav. 28, 29\u201333 (1987).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"2716_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.physbeh.2014.05.032","volume":"135","author":"A Ennaceur","year":"2014","unstructured":"Ennaceur, A. Tests of unconditioned anxiety\u2014pitfalls and disappointments. Physiol. Behav. 135, 55\u201371 (2014).","journal-title":"Physiol. Behav."},{"key":"2716_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fphar.2018.01225","volume":"9","author":"O Engel","year":"2018","unstructured":"Engel, O. et al. Imepitoin shows benzodiazepine-like effects in models of anxiety. Front. Pharm. 9, 1225 (2018).","journal-title":"Front. Pharm."},{"key":"2716_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00429548","volume":"42","author":"MT Silva","year":"1975","unstructured":"Silva, M. T. & Calil, H. M. Screening hallucinogenic drugs: systematic study of three behavioral tests. Psychopharmacologia 42, 163\u2013171 (1975).","journal-title":"Psychopharmacologia"},{"key":"2716_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/0269881107073199","volume":"21","author":"SC Stanford","year":"2007","unstructured":"Stanford, S. C. The Open Field Test: reinventing the wheel. J. Psychopharmacol. 21, 134\u2013135 (2007).","journal-title":"J. Psychopharmacol."},{"key":"2716_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-2999(87)90648-0","volume":"142","author":"T Nagatani","year":"1987","unstructured":"Nagatani, T., Yamamoto, T., Sugihara, T. & Ueki, S. The effect of agonists at the GABA-benzodiazepine receptor complex on the duration of immobility of mice in the forced swimming test. Eur. J. Pharmacol. 142, 17\u201322 (1987).","journal-title":"Eur. J. Pharmacol."},{"key":"2716_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0028-3908(93)90167-2","volume":"32","author":"V Van der Meersch-Mougeot","year":"1993","unstructured":"Van der Meersch-Mougeot, V. et al. Benzodiazepines reverse the anti-immobility effect of antidepressants in the forced swimming test in mice. Neuropharmacology 32, 439\u2013446 (1993).","journal-title":"Neuropharmacology"},{"key":"2716_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/21623945.2020.1736734","volume":"9","author":"V Sica","year":"2020","unstructured":"Sica, V., Martins, I., Moti\u00f1o, O., Bravo-San Pedro, J. M. & Kroemer, G. Antibody-mediated neutralization of ACBP\/DBI has anorexigenic and lipolytic effects. Adipocyte 9, 116\u2013119 (2020).","journal-title":"Adipocyte"},{"key":"2716_CR38","first-page":"829","volume":"23","author":"H Kobayashi","year":"1988","unstructured":"Kobayashi, H., Maeda, M., Hayata, T. & Kawashima, Y. Clinical study of combination chemotherapy with CDDP, ADM and CPM for ovarian cancer. Nihon Gan Chiryo Gakkai Shi 23, 829\u2013836 (1988).","journal-title":"Nihon Gan Chiryo Gakkai Shi"},{"key":"2716_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12442","volume":"17","author":"AL Ujjainwala","year":"2018","unstructured":"Ujjainwala, A. L., Courtney, C. D., Rhoads, S. G., Rhodes, J. S. & Christian, C. A. Genetic loss of diazepam binding inhibitor in mice impairs social interest. Genes Brain Behav. 17, e12442 (2018).","journal-title":"Genes Brain Behav."},{"key":"2716_CR40","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1073\/pnas.80.11.3531","volume":"80","author":"A Guidotti","year":"1983","unstructured":"Guidotti, A. et al. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl Acad. Sci. USA 80, 3531\u20133535 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2716_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0196-9781(98)00037-0","volume":"19","author":"JG De Mateos-Verchere","year":"1998","unstructured":"De Mateos-Verchere, J. G., Leprince, J., Tonon, M. C., Vaudry, H. & Costentin, J. The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment. Peptides 19, 841\u2013848 (1998).","journal-title":"Peptides"},{"key":"2716_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-2478(85)90047-1","volume":"10","author":"JM Cavaillon","year":"1985","unstructured":"Cavaillon, J. M. & Haeffner-Cavaillon, N. The role of serum in interleukin 1 production by human monocytes activated by endotoxins and their polysaccharide moieties. Immunol. Lett. 10, 35\u201341 (1985).","journal-title":"Immunol. Lett."},{"key":"2716_CR43","doi-asserted-by":"crossref","unstructured":"de Mateos-Verchere, J. G., Leprince, J., Tonon, M. C., Vaudry, H. & Costentin, J. The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur. J. Pharmacol. 414, 225\u2013231 (2001).","DOI":"10.1016\/S0014-2999(01)00771-3"},{"key":"2716_CR44","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/sj.npp.1301280","volume":"32","author":"J-C do Rego","year":"2007","unstructured":"do Rego, J.-C. et al. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology 32, 1641\u20131648 (2007).","journal-title":"Neuropsychopharmacology"},{"key":"2716_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuroscience.2007.09.012","volume":"150","author":"K Matsuda","year":"2007","unstructured":"Matsuda, K. et al. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish. Neuroscience 150, 425\u2013432 (2007).","journal-title":"Neuroscience"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2716-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2716-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2716-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:05:25Z","timestamp":1760087125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2716-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2716-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.K. and J.M.B.-S.P. filed a patent application dealing with targeting the ACBP\/DBI system in anorexia, obesity, and co-morbidities. G.K. filed additional patent applications dealing with caloric restriction mimetics (autophagy inducers) for the treatment of aging, age-related diseases, cancer, obesity, and co-morbidities. G.K. is a scientific co-founder of Samsara Therapeutics and Therafast Bio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"502"}}